This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

June 22 - 24, 2021
🖧 VIRTUAL EVENT

Emerging Trends, Best Practices and Benchmarking for Managing Risks Associated with Complex, High‑Touch Therapies

The life sciences industry’s must-attend conference catered to the unique legal and compliance challenges for specialty pharmaceutical companies focused on rare, ultra‑rare and orphan diseases.

Compliance Frameworks for Top Specialty Pharmaceutical Challenges


Analyze Recent Enforcement Trends, Regulatory Actions and Pending Policies
Analyze Recent Enforcement Trends, Regulatory Actions and Pending Policies
  • Hear directly from the leading attorneys from the Department of Justice (DOJ) spearheading the charge against healthcare fraud
  • Benchmark with colleagues on response and actions related to the Special Fraud and Abuse Alert on Speaker Programs
  • Gain insight from top law firms including Sidley Austin LLP, Covington and Burling LLP and Choate
Ensure Business Continuity Through the Everchanging Legal Landscape
Ensure Business Continuity Through the Everchanging Legal Landscape
  • Discuss how to institute a culture of compliance from the top and how it can act as a role model for the organization with Top CCO's from leading specialty
  • Forecast priorities for 2021 and beyond through roundtables based on your company’s size and maturity level
  • Understand the long terms impacts of COVID-19 and what compliance could have done better to prepare
  • Benefit from the 3rd Annual Invitation Only Legal and Compliance Leadership Summit
Assess Risks and Strengthen Controls Around Patient and Provider Support Activities
Assess Risks and Strengthen Controls Around Patient and Provider Support Activities
  • Define the firewalls that should be in place when working with medical affairs and the commercial team
  • Navigate the risk and merits of patient support activities and develop strategies for promoting appropriate business engagements with patient advocacy organizations
  • Identify compliant ways to measure nurse educator effectiveness and key considerations that impact program design

Associate Director, Compliance

PTC Therapeutics

Great information for someone starting out in specialty pharma.

AN INSIDE LOOK AT OUR COMPLIANCE CONGRESS FOR SPECIALTY PRODUCTS COMMUNITY

Attendance by Company Type:

77%
Bio | Pharma
15%
Consultant | Solutions Provider
4%
Government
4%
Non-Profit | Higher Education

Continuing Education Credits

Attendance at the Compliance Congress for Specialty Products provides eligibility for CPE and CLE credits* (pending final approval*)

All credits will be provided following the conclusion of the event

Connect and Network with Key Decision-Makers at the Compliance Congress for Specialty Products

Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, please contact:

Derek Tagliarino: DerekT@informaconnectls.com | +1-212-600-3433 

Who Should Attend

You will benefit from attending our next Compliance Congress for Specialty Products if you work at a specialty pharma or biotech company and have responsibilities in the following areas:


  • Ethics / Compliance

  • Legal / Counsel

  • Monitoring

  • Audit

  • Privacy

  • Regulatory Affairs

  • Medical Affairs

  • Risk Management


Compliance Congress for Specialty Products also benefits

Law Firms, Consultants and Service Providers focused on compliance.

GET SOCIAL WITH US | #SpecialtyCompliance2021


JOIN US ON LINKEDIN
JOIN US ON LINKEDIN
CLICK TO JOIN
JOIN US ON TWITTER
JOIN US ON TWITTER
CLICK TO JOIN
JOIN US ON FACEBOOK
JOIN US ON FACEBOOK
CLICK TO JOIN